Trials of Plasma From Recovered Covid-19 Patients Have Begun

US Food and Drug Administration officials announced today they have approved plans for nationwide trials of two treatments for Covid-19, the global pandemic disease caused by the new coronavirus—and for their simultaneous use in perhaps hundreds of hospitals.The therapeutic agents—convalescent plasma and hyperimmune globulin—are both derived from the blood of people who have recovered from…

Details